SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019
21 oct. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020
03 oct. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
26 sept. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019
25 sept. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019
28 août 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox
08 juil. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019
18 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies to Host Business Update Webcast on June 18, 2019
11 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets
03 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
20 mai 2019 16h30 HE
|
SIGA Technologies Inc.
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...